40 In patients with T2DM, the SURPASS-2 trial compared tirzepatide with semaglutide 1 mg (both as add-on therapies to metformin) and found tirzepatide was either noninferior or superior at all doses (5 mg, 10 mg 15 mg), for both HbA 1c reduction and weight loss at 40 weeks
Similar principles apply to eating on tirzepatide and creating a semaglutide diet plan or tirzepatide diet plan
Using FDA-approved therapies like tirzepatide and semaglutide with close medical supervision, patients achieve meaningful, sustained weight loss and improved metabolic health
GLP-1s improve insulin sensitivity, helping the body process carbohydrates more efficiently
- Katie Hoehn, RD, CSSD, CSCS Sports Performance Dietitian supporting weight-loss clients, including individuals using GLP-1 medications
And for good reasonthey work